CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Outcomes Associated With the Use of Polyglactin 910 (Vicryl®) and Polypropylene (Prolene®) Suture, and Polydioxanone (StratafixTM Spiral PDS® Plus) and Combination of 2-Octyl Cyanoacrylate and Polyester Mesh (Dermabond Prineo®) for Multi-Layer Wound Closure Following Excision of Giant Benign Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05240820
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:47.857670+00:00
Published At: 2022-02-15T00:00:00+00:00
Record Updated At: 2022-02-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Scar Quality Assessment and Safety"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-02-15"
protocolSection.identificationModule.nctId: "NCT05240820"
protocolSection.identificationModule.officialTitle: "Clinical Outcomes Associated With the Use of Polyglactin 910 (Vicryl\u00ae) and Polypropylene (Prolene\u00ae) Suture, and Polydioxanone (StratafixTM Spiral PDS\u00ae Plus) and Combination of 2-Octyl Cyanoacrylate and Polyester Mesh (Dermabond Prineo\u00ae) for Multi-Layer Wound Closure Following Excision of Giant Benign Tumors"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.